Ordinary Rebalance | Solactive China Healthcare Disruption Index | Effective Date 1st December 2022
Solactive China Healthcare Disruption Index:
In the ordinary rebalancing effective open December 01, 2022 the following index composition was implemented:
3SBIO INC | 1.3032 % |
AIM VACCINE CO LTD | 1.7454 % |
AK MEDICAL HOLDINGS LTD | 0.5557 % |
AKESO INC | 1.825 % |
ALIBABA HEALTH INFORMATION TECHNOLOGY LTD | 5.5959 % |
ANGELALIGN TECHNOLOGY INC | 1.0565 % |
CANSINO BIOLOGICS INC | 2.1093 % |
CHINA MEDICAL SYSTEM HOLDINGS LTD | 1.7984 % |
CSPC PHARMACEUTICAL GROUP LTD | 7.7217 % |
GENSCRIPT BIOTECH CORP | 2.7063 % |
GRAND PHARMACEUTICAL GROUP LTD | 0.9449 % |
GUSHENGTANG HOLDINGS LTD | 0.6305 % |
HANSOH PHARMACEUTICAL GROUP CO | 5.662 % |
INNOCARE PHARMA LTD | 1.2637 % |
INNOVENT BIOLOGICS INC | 3.0422 % |
JD HEALTH INTERNATIONAL INC | 8.2672 % |
JOINN LABORATORIES CHINA C-H | 2.2831 % |
KEYMED BIOSCIENCES INC | 0.9159 % |
LIFETECH SCIENTIFIC CORP | 0.7527 % |
LIVZON PHARMACEUTICAL GROUP INC | 2.286 % |
LUYE PHARMA GROUP LTD | 0.699 % |
MICROPORT SCIENTIFIC CORP | 2.1631 % |
PING AN HEALTHCARE AND TECHNOL | 1.4102 % |
REMEGEN CO LTD-H | 2.4011 % |
SHANDONG WEIGAO GROUP MEDICAL POLYMER CO LTD | 3.3217 % |
SHANGHAI BIO-HEART BIOLOGI-H | 0.2967 % |
SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD | 6.5379 % |
SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO LTD | 0.8276 % |
SHANGHAI JUNSHI BIOSCIENCES CO LTD | 3.8286 % |
SHANGHAI MICROPORT MEDBOT GR | 1.8565 % |
SIMCERE PHARMACEUTICAL GROUP | 1.7645 % |
SINO BIOPHARMACEUTICAL LTD ORD | 5.5813 % |
WUXI APPTEC CO LTD | 7.3941 % |
WUXI BIOLOGICS CAYMAN INC | 7.727 % |
ZAI LAB LTD | 1.725 % |